Industry News
Pharmaceutical Industry News
President Donald Trump has…
President Donald Trump has delivered another blow in his ongoing battle with the pharma industry, signing a memorandum on Tuesday that directs the FDA to rein in direct-to-consumer (DTC) drug advertising.
How Gen Z Protests Overturned a Government, and a Crackdown on TV Drug Ads
Plus, 7-Eleven’s new master plan.
The drug-releasing system combo is…
The drug-releasing system combo is approved to treat patients with bladder cancer who face removal of the organ after not responding to the standard-of-care Bacillus Calmette-Guérin treatment in the first-line setting.
In a bid to save around 8 billion…
In a bid to save around 8 billion Danish kroner ($1.3 billion) annually by the end of 2026, Novo will lay off roughly 9,000 employees across its global workforce of 78,400. Some 5,000 job cuts
Six months after Walgreens and…
Six months after Walgreens and three other retailers brought an antitrust lawsuit against Takeda and TWi Pharmaceuticals over an alleged “pay-for-delay” scheme, CVS has filed a similar antitrust complaint against the same companies.
Eli Lilly has partnered with…
Eli Lilly has partnered with Julianne Moore, tapping into the actor’s experience in the movie “Still Alice” to encourage people to prioritize brain health.
Trump Moves to Crack Down on Drug Advertising
The administration is proposing a return to a 1990s-era policy that kept most drug ads off TV. That could dent the revenues of drugmakers and major networks.
RFK Jr. Releases Childhood Health Report
The report, which follows a draft leaked last month, demonstrates both the ambitions and limits of Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.
Ahead of New York Fashion Week,…
Ahead of New York Fashion Week, Gilead Sciences is strutting its marketing stuff to raise awareness of primary biliary cholangitis.
Policy recommendations released…
Policy recommendations released Tuesday by the RFK Jr.-led commission were light on details but included plans to ramp up research and potential oversight on some of the secretary's more controversial focus areas.
In a keynote session Tuesday at…
In a keynote session Tuesday at the Fierce Pharma Week 2025 conference in Philadelphia, Sigler spoke about the decision to open up about her MS diagnosis, the positive impacts it’s had on her life and
Effective Tuesday, Ryan Quigley…
Effective Tuesday, Ryan Quigley has stepped into the CEO role at Inizio. He’s succeeding Paul Taaffe, who has served as chief executive since Inizio’s 2022 founding.
Lundbeck is making a big push on…
Lundbeck is making a big push on the company’s capital reallocation initiative, handing over its operations in 27 markets to partners.
Regeneron and Sandoz have reached…
Regeneron and Sandoz have reached a settlement that resolves all patent litigation related to the Swiss company’s biosimilar version of eye disease drug Eylea.
The private equity firm is looking…
The private equity firm is looking to attract other private equity buyers to take on the CDMO for a valuation of up to $4 billion, the Financial Times reported on Sept. 6.
Samsung Biologics has secured a…
Samsung Biologics has secured a contract manufacturing deal to run through Dec. 31, 2029, which will net the CDMO 1.8 trillion Korean won (roughly $1.3 billion). Samsung Bio noted that the contract timeline could be
You Might Have Already Fallen for MAHA’s Conspiracy Theories
How does MAHA turn some health-conscious people against all health care? We found out.
ICER has high confidence in the…
ICER has high confidence in the drugs' cost-effectiveness, but it also voiced concerns over the drugs' impact on healthcare budgets.
Endo is ramping up the next phase…
Endo is ramping up the next phase of its Dupuytren's contracture marketing drive. Not long after running its first branded ad for Xiaflex in the indication, the drugmaker has dubbed September the first annual National
¿Por qué cada vez más personas mayores mueren tras caídas?
Algunos investigadores sospechan que el aumento del consumo de medicamentos con receta puede explicar una tendencia preocupante.